GSP Crop Science submitted Q3 & 9M FY26 investor presentation pursuant to SEBI Regulation 30.
Consolidated revenue grew 14% to ₹11,146M with EBITDA up 32% and PAT up 26% for 9MFY26.
Growth driven by domestic B2C segment including new product sales of ₹366M and geographic expansion.
Exports grew 20% with new registrations in Brazil, Africa, Middle East, and Asian countries.